Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Ophthalmology | 7 | 2021 | 1840 | 2.11 | Why? |
| Fluorescein Angiography | 4 | 2018 | 426 | 1.61 | Why? |
| Uveitis | 2 | 2020 | 233 | 1.21 | Why? |
| Tomography, Optical Coherence | 3 | 2018 | 1008 | 1.19 | Why? |
| Retinal Vein Occlusion | 2 | 2017 | 129 | 1.15 | Why? |
| Hong Kong | 9 | 2020 | 3361 | 0.92 | Why? |
| Intraocular Pressure | 3 | 2020 | 276 | 0.88 | Why? |
| Aqueous Humor | 2 | 2017 | 82 | 0.83 | Why? |
| Porphyrins | 2 | 2018 | 88 | 0.75 | Why? |
| Eye Diseases | 2 | 2020 | 1150 | 0.75 | Why? |
| Central Serous Chorioretinopathy | 1 | 2018 | 20 | 0.74 | Why? |
| Prosthesis Retention | 1 | 2017 | 1 | 0.73 | Why? |
| Orbital Implants | 1 | 2017 | 1 | 0.73 | Why? |
| Eye, Artificial | 1 | 2017 | 2 | 0.73 | Why? |
| Orbit Evisceration | 1 | 2017 | 3 | 0.72 | Why? |
| Iris | 1 | 2017 | 27 | 0.71 | Why? |
| Capillaries | 2 | 2017 | 257 | 0.70 | Why? |
| Cefuroxime | 1 | 2017 | 17 | 0.70 | Why? |
| Retinal Vein | 1 | 2017 | 16 | 0.69 | Why? |
| Lasers, Solid-State | 1 | 2017 | 56 | 0.68 | Why? |
| Magnetic Phenomena | 1 | 2017 | 148 | 0.67 | Why? |
| Glaucoma, Angle-Closure | 1 | 2017 | 46 | 0.67 | Why? |
| Ophthalmologic Surgical Procedures | 1 | 2020 | 211 | 0.67 | Why? |
| Photosensitizing Agents | 2 | 2018 | 279 | 0.64 | Why? |
| Ranibizumab | 1 | 2017 | 103 | 0.64 | Why? |
| Blood Loss, Surgical | 1 | 2018 | 211 | 0.62 | Why? |
| Phacoemulsification | 1 | 2018 | 102 | 0.62 | Why? |
| Postoperative Hemorrhage | 1 | 2018 | 183 | 0.61 | Why? |
| Text Messaging | 1 | 2020 | 389 | 0.60 | Why? |
| Endophthalmitis | 1 | 2017 | 105 | 0.60 | Why? |
| Visual Acuity | 4 | 2018 | 790 | 0.59 | Why? |
| Laser Therapy | 1 | 2017 | 158 | 0.58 | Why? |
| Interferon-gamma Release Tests | 1 | 2017 | 253 | 0.58 | Why? |
| Prosthesis Implantation | 1 | 2017 | 261 | 0.56 | Why? |
| Cataract | 1 | 2018 | 186 | 0.56 | Why? |
| Retinal Vessels | 1 | 2017 | 255 | 0.54 | Why? |
| Ophthalmologists | 1 | 2020 | 401 | 0.53 | Why? |
| Latent Tuberculosis | 1 | 2017 | 324 | 0.50 | Why? |
| Microcirculation | 1 | 2017 | 447 | 0.49 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.49 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.43 | Why? |
| Patient Compliance | 1 | 2020 | 1468 | 0.42 | Why? |
| Hand Hygiene | 1 | 2020 | 1493 | 0.39 | Why? |
| Respiratory Protective Devices | 1 | 2020 | 1637 | 0.36 | Why? |
| Reconstructive Surgical Procedures | 1 | 2017 | 860 | 0.34 | Why? |
| Coronavirus | 3 | 2020 | 18339 | 0.32 | Why? |
| Fundus Oculi | 2 | 2017 | 237 | 0.32 | Why? |
| Eye | 2 | 2020 | 374 | 0.31 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.29 | Why? |
| Thromboembolism | 1 | 2018 | 2101 | 0.28 | Why? |
| Conjunctiva | 2 | 2021 | 620 | 0.28 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.22 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.21 | Why? |
| Masks | 2 | 2020 | 8528 | 0.21 | Why? |
| Amnion | 1 | 2020 | 55 | 0.20 | Why? |
| Indocyanine Green | 2 | 2018 | 66 | 0.19 | Why? |
| Tonometry, Ocular | 1 | 2020 | 108 | 0.19 | Why? |
| Filtering Surgery | 1 | 2017 | 6 | 0.19 | Why? |
| Ciliary Body | 1 | 2017 | 12 | 0.18 | Why? |
| Lasers, Semiconductor | 1 | 2017 | 16 | 0.18 | Why? |
| Sclera | 1 | 2017 | 31 | 0.18 | Why? |
| Tuberculosis, Ocular | 1 | 2017 | 14 | 0.18 | Why? |
| Laser Coagulation | 1 | 2017 | 33 | 0.18 | Why? |
| Endothelium, Corneal | 1 | 2017 | 41 | 0.17 | Why? |
| Orbital Neoplasms | 1 | 2017 | 27 | 0.17 | Why? |
| Anterior Chamber | 1 | 2017 | 26 | 0.17 | Why? |
| Photochemotherapy | 2 | 2018 | 297 | 0.17 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.17 | Why? |
| Coloring Agents | 1 | 2018 | 116 | 0.17 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.16 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.16 | Why? |
| Vitreous Body | 1 | 2017 | 161 | 0.16 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.16 | Why? |
| Humans | 26 | 2021 | 930598 | 0.16 | Why? |
| Follow-Up Studies | 5 | 2018 | 17020 | 0.16 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Eye Infections, Bacterial | 1 | 2017 | 86 | 0.15 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.15 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.15 | Why? |
| Postoperative Period | 1 | 2017 | 651 | 0.15 | Why? |
| Intravitreal Injections | 1 | 2017 | 347 | 0.14 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.14 | Why? |
| Prosthesis Design | 1 | 2017 | 594 | 0.14 | Why? |
| Antibiotic Prophylaxis | 1 | 2017 | 399 | 0.13 | Why? |
| Carcinoma | 1 | 2017 | 256 | 0.13 | Why? |
| Cataract Extraction | 1 | 2017 | 201 | 0.13 | Why? |
| Glaucoma | 1 | 2017 | 225 | 0.13 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.13 | Why? |
| Retina | 1 | 2018 | 424 | 0.13 | Why? |
| Angiogenesis Inhibitors | 1 | 2017 | 395 | 0.13 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.11 | Why? |
| Infection Control | 4 | 2021 | 23131 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.10 | Why? |
| Sputum | 1 | 2017 | 1720 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.09 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.09 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Male | 10 | 2020 | 367725 | 0.08 | Why? |
| Time Factors | 3 | 2018 | 31397 | 0.08 | Why? |
| Aged | 8 | 2020 | 215776 | 0.07 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.07 | Why? |
| Female | 9 | 2020 | 380317 | 0.07 | Why? |
| Choroidal Neovascularization | 1 | 2004 | 96 | 0.06 | Why? |
| Middle Aged | 7 | 2020 | 270681 | 0.06 | Why? |
| Choroid | 1 | 2004 | 112 | 0.06 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.06 | Why? |
| Treatment Outcome | 3 | 2017 | 51732 | 0.06 | Why? |
| Postoperative Complications | 2 | 2017 | 5861 | 0.06 | Why? |
| Glucocorticoids | 1 | 2017 | 4431 | 0.06 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.05 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| Prospective Studies | 2 | 2017 | 43301 | 0.03 | Why? |
| Adult | 3 | 2020 | 244371 | 0.03 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Child | 1 | 2017 | 70012 | 0.02 | Why? |
| Retinal Hemorrhage | 1 | 2004 | 50 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Retinal Detachment | 1 | 2004 | 146 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| China | 1 | 2017 | 50654 | 0.01 | Why? |
Li's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_